XZB-0004

· Xuanzhu Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XZB-0004, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XZB-0004 in Patients With Solid Tumors [Phase 1]